MicroPort NeuroTech Ltd. logo

MicroPort NeuroTech Ltd. (2172)

Market Open
12 Aug, 08:00
HKEX HKEX
8. 98
HKD
-0.02
-0.2221%
HKD
5.44B Market Cap
- P/E Ratio
0.32% Div Yield
1.5M Volume
- Eps
9.01 HKD
Previous Close
Add Transaction
Day Range
8.95 9.1
Year Range
8.4 16.43
Want to track 2172 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2172 trading today lower at 8.98 HKD, a decrease of -0.2221% from yesterday's close, completing a monthly decrease of -20.4867% or -2.32 HKD. Over the past 12 months, 2172 stock lost -20.4867%.
2172 pays dividends to its shareholders, with the most recent payment made on Sep 26, 2025. The next announced payment will be in In 1 weeks on Aug 21, 2026 for a total of 0.09 HKD.
The last earnings report, released on Apr 01, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

2172 Chart

People also search for

Luye Pharma Group Ltd.
2.12 HKD
+0.9501%
Carsgen Therapeutics Holdings Limited
15.9 HKD
+0.5057%
Beijing Biostar Pharmaceuticals, Co., Ltd.
3.5 HKD
-1.1299%
Aim Vaccine Co. Ltd.
1.55 HKD
+1.6393%
CK Life Sciences Int'l.,
0.56 HKD
0%

MicroPort NeuroTech Ltd. (2172) FAQ

What is the stock price today?

The current price is 8.98 HKD.

On which exchange is it traded?

MicroPort NeuroTech Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2172.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.32%.

What is its market cap?

As of today, the market cap is 5.44B.

Has MicroPort NeuroTech Ltd. ever had a stock split?

No, there has never been a stock split.

MicroPort NeuroTech Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Zhiyong Xie CEO
HKEX Exchange
KYG6083E1098 ISIN
China Country
534 Employees
2 Jul 2026 Last Dividend
- Last Split
- IPO Date

Overview

MicroPort NeuroTech Limited is a powerhouse in the neuro-interventional medical devices sector, focusing on groundbreaking research and development, alongside the production and sale of its innovative products. Since its establishment in 2004, the company has been at the forefront of offering advanced solutions in the medical field, catering not only to the People's Republic of China but also to an international clientele. Headquartered in Shanghai, the company is driven by a commitment to improving patient outcomes in the treatment of complex neurovascular conditions.

Products and Services

  • NUMEN - A coil embolization system designed for the endovascular treatment of cerebral aneurysms, providing a minimally invasive option for patients.
  • NUMEN FR - A coil detachment system that complements the NUMEN embolization system, enabling precise control and deployment of embolization coils.
  • NUMEN Silk - Further extending the NUMEN product line, offering advanced features for enhanced performance in coil embolization procedures.
  • Tubridge - A flow-diverting stent that redirects blood flow away from an aneurysm, promoting healing and the prevention of rupture.
  • Willis - An intracranial stent graft system used in the treatment of wide-necked intracranial aneurysms, providing a scaffold for vessel reconstruction.
  • Comaneci - An adjustable temporary coil embolization device that aids in the dense packing of aneurysms without the need for permanent implantation.
  • Rebridge - An intracranial visualized stent designed for use in the treatment of hemorrhagic stroke, offering a new approach to vascular repair and recovery.
  • APOLLO - An intracranial stent and a balloon-expandable stent system tailored for treating intracranial atherosclerotic disease.
  • Bridge - A rapamycin target eluting vertebral artery stent system, facilitating targeted drug release to prevent restenosis after stent implantation.
  • Diveer - An intracranial balloon catheter specifically designed for the treatment of cerebral atherosclerosis stenosis, optimizing artery dilation.
  • Neurohawk - A stent thrombectomy device employed in the rapid and efficient removal of thrombi in cases of acute ischemic stroke.
  • X-Track and W-track - Specialized catheter products for distal access and intracranial aspiration, enhancing the maneuverability and effectiveness of endovascular procedures.
  • Tigertriever - An adjustable stent retriever that offers a customizable approach to the mechanical revascularization in the treatment of acute ischemic stroke.
  • Asahi Neurovascular Guidewires and U-track support catheter - Essential tools that provide support and navigation during complex neurovascular interventions.

Contact Information

Address: Zhangjiang High-tech Park
Phone: 86 21 3895 4600